Inclusion Criteria:

For patients

- Women with breast cancer and / or ovarian cancer meet criteria suggestive of a
hereditary predisposition

- Deleterious mutation of BRCA1 and BRCA2 sought and not highlighted

- Age ≥ 18 years

- Agreeing to participate in the study (a collection of signed informed consent)

For control population

- Women with no history of breast and / or ovarian cancer and no family history of
breast and / or ovarian cancer among family members on the 1st and 2nd degree before
age 50 for breast cancer and before 60 years for ovarian cancer

- Agreeing to participate in the study (a collection of signed informed consent)

Exclusion Criteria:

For patients:

- Patients with a known deleterious mutation in BRCA1 and BRCA2

- Patients do not meet criteria suggestive of a hereditary predisposition

- Persons deprived of liberty or under guardianship (including guardianship)

For control population:

- Males

- Personal or family history of breast and / or ovarian cancer (breast or ovarian
cancer in their family experienced 1st and 2nd degree before age 50 for breast cancer
before age 60 for cancer ovarian)

- Persons deprived of liberty or under guardianship (including guardianship)